Waist Circumference Measurements in Schizophrenic Patients
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01243034|
Recruitment Status : Unknown
Verified October 2010 by Changhua Christian Hospital.
Recruitment status was: Not yet recruiting
First Posted : November 18, 2010
Last Update Posted : November 18, 2010
The prevalence of metabolic syndrome(MS) among pt's with schizophrenia has been reported to be high, ranging from 24 to 43% in males and 27 to 52% in females. Schizophrenic patients with MS have an increased incidence of DM, coronary heart disease and increased mortality from cardiovascular diseases. Central adiposity is highly correlated with the presence of hypertension, coronary heart disease, type 2 diabetes, and increased mortality risk. Waist circumference(WC) is a better indicator of abdominal obesity and a better predictor of CVD than either BMI or waist-to-hip ratio. However, currently there is no standard location for the measurement of WC.
Objectives: 1. To compare the magnitude of WC measured at 3 sites ( immediately above the iliac crest, midpoint between the lowest rib and the iliac crest , umbilical level) in males and females.
2. To examine the correlation of WC with Triglyceride, cholesterol, HDL, LDL and glucose.
|Condition or disease|
|Waist Circumference Measurements Schizophrenia Cardiovascular Risk Factor|
|Study Type :||Observational|
|Estimated Enrollment :||80 participants|
|Official Title:||Variability of Waist Circumference Measurements at 3 Sites and Its Relationship With Cardiovascular Risk Factors in Patients With Schizophrenia|
|Study Start Date :||November 2010|
|Estimated Primary Completion Date :||September 2011|
|Estimated Study Completion Date :||October 2011|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01243034
|Changhua Christian Hospital|
|Changhua, Taiwan, 500|